The moderate but consistent upregulation of Fgfr1 and Ppargc1a observed in mice with less hepatic involvement supports the hypothesis that these genes may participate in adaptive metabolic pathways that mitigate steatosis. The gene discussed is PPARGC1A; the disease is steatosis.